Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortAnti-IgE injection for allergic asthma and chronic hives.Anti-IL-5 antibody for severe eosinophilic asthma.
Body systemLungs & BreathingLungs & Breathing
Drug classAsthma biologicsAsthma biologics
SupplyPrescription onlyPrescription only
Main usesSevere allergic asthma, Chronic spontaneous urticaria (hives), Nasal polyps, Food allergy (US)Severe eosinophilic asthma, Nasal polyps, Eosinophilic granulomatosis with polyangiitis
How it worksBlocks the allergy antibody IgE.Lowers a type of white cell that drives severe asthma.
Starts workingWeeks to monthsWeeks to months
Half-lifeAbout 26 daysAbout 16–22 days
Typical adult dose75–600 mg every 2 or 4 weeks, based on body weight and IgE level for asthma; 150–300 mg every 4 weeks for hives.100 mg subcutaneously every 4 weeks for asthma.
FormsSubcutaneous injectionSubcutaneous injection
Common side effectsInjection site reactions, Headache, Sore throat, Joint painHeadache, Injection site reactions, Back pain, Tiredness
Serious side effectsAnaphylaxis (rare), Parasite infection risk, Heart or stroke events (possible)Allergic reactions, Shingles, Parasite infections
Don't take ifPrevious anaphylaxis to omalizumabPrevious severe hypersensitivity to mepolizumab
AlcoholUsually no problem in moderation. No known interaction.Usually no problem in moderation. No known interaction.
PregnancyUse with cautionUsed if needed; data do not show harm.Use with cautionLimited data.
BreastfeedingGenerally considered safeAntibodies pass into milk in small amounts.Generally considered safeAntibodies pass into milk in small amounts.
In use since——
Brand namesUnited States: XolairUnited Kingdom: XolairIndia: Xolair, Omalizumab (generic)United States: NucalaUnited Kingdom: NucalaIndia: Nucala
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H
ATC codeR03DX05R03DX09

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker